Skip to content
o2h discovery website
o2h discovery – seeding new ideas in life science, tech and green …
about
company overview
team
ESG
o2h community
how we deliver
news & insights
news & press releases
blogs
posters
newsletters
white papers
webinars
brochures
events
exhibiting/attending events
o2h Innovation Conference 2026
Bootcamps
AIM squad
Cambridge Wide Open Day
Cambridge TechBIO Caucus
Biotech Bikers
o2h Chaitime Webinar
culture & careers
CITC
TM
o2h group
integrated
(drug discovery)
Target Identification and Validation
Hit Identification
Hit to Lead
Lead Optimization
Targeted protein degradation
Fragment-based Drug Discovery
Knowledge-based drug design and SAR
Early assessment of in vitro ADMET and PK
chemistry
medicinal chemistry services
synthetic chemistry
peptide synthesis service
PROTAC Services
Lipid Nanoparticles (LNPs)
analytical chemistry
ADCs – linker/payloads
catalog
biology
target engagement and validation
PROTAC
NanoBRET/NanoBiT
NaLTSA
CRISPR/Cas9
siRNA/shRNA
Undruggable targets and genetic benchmarking
Assay biology
Biophysical
Biochemical
Cellular
Gene expression
Drug-Drug interactions and synthetic lethality
Biomarker assessment
Site-directed mutagenesis & binding studies
Drug Screening
Iterative screening
Primary, orthogonal and selectivity
Fragment-based screening
Phenotypic screening
Biology Insights
Biochemistry
RNA Binding Small Molecule
High-Content Imaging
Immuno-Oncology Therapeutics
Psychedelics
Read more…
DMPK
in-vitro ADME
ChamelogK Assay
in-vivo Pharmacokinetics (PK)
scale-up
kilo-lab
non-GMP
GMP [partnership]
models
o2h Kickstarter: North America
o2h Kickstarter: Global
o2h Kickstarter: Japan
o2h Biology Match Funding
o2h Plug-in Biotech
o2h Peptide Guarantee
o2h Kickstarter: Innovate America
o2h discovery Inflexion Tx
o2h Platinum Partner
o2h Fast Pharma 18
Power Your Pipeline With India
contact
case studies
Innovating Neurological Drug discovery – Improving Bioavailability of a Novel Compound through Strategic Chemistry & Formulation R&D
Read More →
